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A phytochemical investigation of the whole plant of Crassocephalum bauchiense 
Huch. resulted in the isolation of a new clerodane diterpenoid, ent-2β,18,19-
trihydroxycleroda-3,13-dien-16,15-olide (1) together with two known flavonoids                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
3’,5-dihydroxy-4’,5’,6,7,8-pentamethoxyflavone (2) and 4’,5-dihydroxy-3’,5’,6,7,8-
pentamethoxyflavone (3). The compounds were tested against the chloroquine-sensitive 3D7 
strain of Plasmodium falciparum. Compound 2 showed weak activity (IC50 = 10.1 µg/mL) 
whilst compounds 1 and 3 were inactive. The structures of the compounds were defined by 
detailed spectral analyses, especially 1H- and 13C- NMR, 1H-1H COSY, NOESY, HMBC and 
HR-ESIMS. 
Key words: Crassocephalum bauchiense; isolation; clerodane diterpenoid; flavonoids; 
antiplasmodial activity. 
 
1. Introduction  
Crassocephalum bauchiense Hutch. is an erect bushy annual herb about 1ft. high with 
bright blue florets in numerous heads growing in rough open ground in Nigeria and Cameroon 
(Hutchison & Dalziel 1958). The plant is used in folk medicine in Cameroon to treat 
gastrointestinal infections, liver disorders, epilepsy, pain, arthritis, colics, behavioural 
disturbances in mentally-retarded children, inflammatory disorders and neuropathic pain 
(Arbonnier 2000; Moukeu et al. 2011). In experimental studies, the aqueous extract of the 
leaves showed antinociceptive activity (Taiwe et al 2012) and the fractions antibacterial and 
immunomodulary activities (Mouokeu et al., 2011; 2013). To the best of our knowledge, no 
previous phytochemical study has been done on this plant. 
 In our efforts to investigate Cameroonian medicinal plants for the biological activity of 
their constituents, we carried out a phytochemical study on the dichloromethane-methanol 
(1:1) extract of the titled plant and report herein the isolation and structure elucidation of a 
new clerodane diterpenoid ent-2β,18,19-trihydroxycleroda-3,13-dien-16,15-olide (1), from the 
whole plant of C. bauchiense together with two known flavonoids, 3’,5-dihydroxy-4’,5’,6,7,8-
pentamethoxyflavone (2) and 4’,5-dihydroxy-3’,5’,6,7,8-pentamethoxyflavone (3), identified 
for the first time in the Crassocephalum genus. The isolated compounds were tested against 
the 3D7 strain of Plasmodium falciparum. Compound 2 showed  weak activity.  
 2. Results and discussion 
The crude CH2Cl2-MeOH (1:1) extract of the whole plant of C. bauchiense was subjected 
to a series of silica gel and sephadex LH-20 chromatographic columns to give the new 
diterpenoid (1) and the known flavonoids 3’,5-dihydroxy-4’,5’,6,7,8-pentamethoxyflavone (or 
Gardenin C) (2, Sujata et al. 2013) and 4’,5-dihydroxy-3’,5’,6,7,8-pentamethoxyflavone (3, 
Fushiya et al. 1999) (Fig. 1).  
Compound 1 was isolated as an amorphous solid. Its molecular formula C20H30O5 was 
deduced from the HRESIMS which showed the pseudo-molecular ion peak  [M+Na]+ at m/z 
373.1970. Its IR spectrum exhibited characteristic absorptions for hydroxyl groups (3238 cm-
1), α,β–unsaturated-γ-lactone (1745 cm-1) and double bond (1649 cm-1) (Esquivel et al. 1989). 
The structure of the compound was established from its 1H- and 13C-NMR spectroscopic data 
(Table1), which suggested a clerodane diterpenoid (Esquivel et al., 1989).  
The 13C NMR spectrum of 1 revealed 20 C-atoms, including a lactone carbonyl and two 
trisubstituted double bonds, three methines (one oxygenated), eight methylenes (three 
oxygenated), a secondary methyl group and a tertiary methyl group and two fully substituted 
carbons. The presence of an α,β-unsaturated γ-lactone moiety was evident from the lowfield 
signal of the olefinic proton H-14 (δH 7.35, brs), showing HMBC  correlations with the 
lactone carbonyl C-16 (δC 175.3), C-12 (δC 128.1), C-13 (δC 133.2) and C-15 (δC 70.6). This 
was further supported by the other long range correlations between the oxymethylene protons 
H2-14 ( δH 4.81, brs,) and C-13 and C-16.  
The two methyls signals at δH 0.88 (d, J = 7.8 Hz) and δH 0.82 (s) in the 1H NMR 
spectrum of compound 1 were assigned to Me-17 and Me-20 respectively. The characteristic 
Me-18 and Me-19 of clerodane diterpenoids (Merrit & Ley 1992) were oxidized to 
oxymethylenes which were observed in the 13C NMR spectrum at δC 62.5 [δH 4.19 (H-18a) 
and 3.89 (H-18b), both d, J = 12.8 Hz] and δC 64.5 5 [(δH 4.02 (H-19a) and 3.71 (H-19b), both 
d, J = 10.8 Hz] respectively. The positioning of these methylene groups at C-4 and C-5 was 
based on the observation of HMBC correlations between H-18b and C-3 (δC 128.6) and C-4 
(δC 147.5) and between H-19a and C-6 and C-10 (Table 1).  
Compound 1 is isomeric with a previously reported clerodane, ent-7β,18,19-trihydroxy- 
cleroda-3,13-dien-16,15-olide, isolated from another source (Esquivel et al., 1989). In 
addition, their NMR data are very close, the difference being the position of the 
secondaryhydroxyl group which was fixed at C-2 (δC 68.1) in 1 by the HMBC correlations 
observed between H-2 (δH 4.28,) and C-1, C-3 and C-4. The HMBC correlation between H2-1 
and C-2 as well as the COSY connectivity between H2-1 and H-2 further confirmed the 
attachment of the hydroxyl group at C-2.  
The relative configuration of compound 1 was determined from the NOESY spectrum 
(Table 1) and by comparison of NMR data with those of reported analogues (Das et al. 2005; 
Esquivel et al. 1989; Gu et al. 2014). The important NOESY cross peaks included those 
between H-10 and H-2 and H-8 one one hand, Me-17 and Me-20 and H-19a on the other 
hand. These results revealed the trans AB-ring junction and the relative configurations at C-2, 
C-8 and C-9.  
In vitro antiplasmodial activity of compounds 1, 2 and 3 was evaluated against the 
chloroquino-sensitive 3D7 strain of P. falciparum. Compound 2 was moderately active (IC50 
= 10.1 µg/mL) whilst compounds 1 and 3 were inactive (IC50 > 40 µg/mL). However, at 
higher concentrations, compound 3 inhibited 42% of the parasites. Compounds 2 and 3 have 
the same A and B rings. The two flavonoids differ in the positions of the hydroxy and 
methoxy groups in ring B. The presence of these groups at C-3’ and C-4’ in compound 1 may 
be responsible for his activity while the positions of these groups in compound 3 may account 
for the reduction in activity.  
 
3. Experimental  
4.1 General experimental procedures 
The optical activity was determined with an AA-10 Automatic (ANALIS) polarimeter  The 
UV spectra were recorded with an U-2910 spectrometer (λmax in nm). The IR spectrum was 
recorded on a Perkin-Elmer 1750 FTIR spectrometer. The HRESI mass spectra were recorded 
with a Bruker APEX-Qe 9.4T Fourier transform ion cyclotron resonance (FTICR) mass 
spectrometer equipped with a hybrid quadrupole analyzer and using an electrospray source. 	  
NMR spectra were recorded in MeOH-d4 on a Bruker 500 MHz NMR AV II spectrometer 
equipped with a cryoprobe, with TMS as an internal reference. Chemical shifts were recorded 
in δ (ppm) and the coupling constants (J) are in hertz (Hz). Column chromatography (CC) 
was carried out on silica gel (70-230 mesh, Merck). TLC was performed on Merck precoated 
silica gel 60 F254 aluminum foil and compounds were detected using 10% sulfuric acid in 
ethanol as spray reagent.  
 
4.2 Plant material 
The whole plant of C. bauchiense was collected at Dschang, in the West Region of 
Cameroon. The botanical identification was done at the National Herbarium in Yaounde 
(Cameroon) by referring to the sample number 7954/SRF/Cam. A voucher specimen of the 
plant is kept in the Herbarium of the Department of Plant Biology of the University of 
Dschang under the code number 0033/UDs/PB. 
 
4.3 Extraction and isolation of compounds 
The whole plant of C. bauchiense was dried at room temperature for two weeks and 
powdered. The powder (1.5 Kg) was macerated with a mixture of CH2Cl2-MeOH (4L, 1:1) for 
two days. After filtration, the solvent was removed under reduced pressure using a rotary 
evaporator (45° C) to yield of 25 g (1.6%) of the crude extract which was further fractionated 
by column chromatography (CC) on 200 g of silica gel 60 with hexane-EtOAc and EtOAc-
MeOH mixtures of increasing polarity. Thirty-three fractions of 300 ml each were collected 
and pooled according to their TLC profile.  Compound 2 (30 mg) crystallized from fraction 
13 collected from the column with the mixture 60:40. Fractions 14-17 collected from the main 
column with the mixtures hexane-EtOAc 60:40 to 50:50 were further chromatographed on a 
silica gel CC with hex-EtOAc (90-10) to yield 29 fractions. Compound 3 (12 mg) crystallized 
from fraction 11. Fraction 28 obtained from the main column with the mixture hexane-EtOAc 
30:70 was chromatographed on a Si gel CC eluting with CHCl3-MeOH (98:2 to 90:10) to give 
13 fractions. Sub-fractions 6 and 7 were regrouped and passed through several Sephadex LH-
20 columns using methanol as eluent to give compound 1 (8 mg).   
Compound 1: Greyish amorphous powder; [α]25D: +23.1 (c 0.03, MeOH); UV (MeOH)  λmax 
215 nm; IR (KBr) 3238, 2952, 2912, 2869, 1745, 1720, 1649, 1448, 1386, 1350, 1209, 1083, 
1039, 842 cm-1; 1H and 13C NMR data see Table 1; HRESIMS: m/z 373.19705 ([M+Na]+, 
calcd. for C20H30NaO5, m/z 373.19855). 
 
4.4 In vitro antiplasmodial assay 
 Continuous culture of the P. falciparum chloroquine sensitive 3D7 strains was 
assessed following the procedure already described in Frederich et al. (2002). The parasites 
were obtained from Prof. Grellier (Museum d’Histoire Naturelle, Paris, France). Each 
compound was applied in a series of eight threefold dilutions from 0.02 to 40 µg/ml for a pure 
substance) on two rows of a 96-well microplate and were tested in triplicate (n=3). Parasite 
growth was estimated by determination of lactate dehydrogenase activity as described 
previously in Kenmogne et al. (2006). Artemisinin (98%, Sigma–Aldrich) and chloroquine 
were used as positive controls (IC50 4.12 ng/mL). 
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Table 1: 1H (500 MHz) and13C NMR (125 MHz) data of compound 1 (recorded in MeOH-d4) 
 
Pos.  δH Mult., J (Hz) δC HMBC 
(1H-13C) 
1H-1H COSY NOESY 
1 1.95 ov 27.1 C-2, C-3, C-10 H-2, H-10 H-2 
2 4.28 brt (7.5) 68.1 C-1, C-3, C-4 H-1, H-3 H-1, H-3, H-10 
3 5.70 brs 128.6 C-1, C-5, C-18   H-2 H-2, H-18b 
4 - - 147.5 - - - 
5 - - 42.9 -  - - 
6a 2.20 ov 30.6 C-8  H-12b, H-6b H-6b 
  b 1.17 dt - C-4, C-5, C-7, C-
19 
H-7, H-6a H-6a, H-10 
7 1.45 m 26.4 - H-6b Me-17 
8 1.59 ov 35.8 - H-17 Me-17 
9 - - 38.1 - - - 
10 1.58 ov 45.0 C-8, C-12 H-9, H-11 H-2, H-6b, H-8,  
11a 1.66 ov 35.8 C-9, C-13, C-12 H-10, H-11 - 
11b 1.54 ov    Me-17 
12a 2.17 ov 18.14 C-8, C-10, C-13 H-12b - 
     b 2.02 ov   H-12a  
13 - - 133.2 - - - 
14 7.35 brs 145.9 C-12, C-13, C-15, 
C-16 
H-15 H2-15 
15 4.81 brs 70.6 C-13, C-16 H-14 H-14 
16 - - 175.3 - - - 














19a 4.02 d(10.8) 64.5 C-4, C-5, C-6, C-
10 
H-19b H-19b, H3-20 
19b 3.71 d(10.8)  C-4, C-6, C-10 H-19a H-19a 




















































Fig. 1 : Structures of the isolated compounds 	  
